We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Celanese to Hike Price for Acetyl Intermediates Products
Read MoreHide Full Article
Celanese Corporation (CE - Free Report) announced that it will increase the list and off-list selling price of acetyl intermediates products. The price hike is effective immediately or as contracts permit.
The company will raise the price of Butyl Acetate in Asia (outside China) by $100/MT. Prices of MIBK and MIBC are slated to increase by 8 cents per MT each in South and North America. Acetic acid price will increase by $50/MT in Asia (outside China) while in China it will increase by ¥300/MT. Also, price of Ethyl Acetate will rise by $80/MT in Asia (outside China) and ¥550/MT in China.
Celanese is taking appropriate pricing actions amid a volatile raw material pricing environment. Pricing improvement drove margins in its Acetyl Chain unit in second-quarter 2017.
Celanese has outperformed the industry over the last three months. The company’s shares have moved up around 10.7% over this period, compared with roughly 2.6% gain recorded by the industry.
Celanese kept its earnings streak alive with a beat in second-quarter 2017. The company logged adjusted earnings of $1.79 per share for the quarter, topping the Zacks Consensus Estimate of $1.74. Celanese sees adjusted earnings per share to increase 9-11% in 2017.
Celanese’s strategic measures including cost savings through productivity actions and pricing initiatives are expected to lend support to its earnings in 2017. The company is also likely to gain from capacity expansion and growth initiatives like acquisitions. Moreover, Celanese remains focused on returning value to shareholders.
Chemours has an expected long-term earnings growth of 15.5%.
Kronos Worldwide has an expected long-term earnings growth of 5%.
BASF has expected long-term earnings growth of 8.6%.
One Simple Trading Idea
Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.
This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.
Image: Bigstock
Celanese to Hike Price for Acetyl Intermediates Products
The company will raise the price of Butyl Acetate in Asia (outside China) by $100/MT. Prices of MIBK and MIBC are slated to increase by 8 cents per MT each in South and North America. Acetic acid price will increase by $50/MT in Asia (outside China) while in China it will increase by ¥300/MT. Also, price of Ethyl Acetate will rise by $80/MT in Asia (outside China) and ¥550/MT in China.
Celanese is taking appropriate pricing actions amid a volatile raw material pricing environment. Pricing improvement drove margins in its Acetyl Chain unit in second-quarter 2017.
Celanese Corporation Price and Consensus | Celanese Corporation Quote
Zacks Rank & Key Picks
Celanese currently carries a Zacks Rank #3 (Hold).
Some better-ranked companies in the chemical space include The Chemours Company (CC - Free Report) , Kronos Worldwide (KRO - Free Report) and BASF SE (BASFY - Free Report) . All three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Chemours has an expected long-term earnings growth of 15.5%.
Kronos Worldwide has an expected long-term earnings growth of 5%.
BASF has expected long-term earnings growth of 8.6%.
One Simple Trading Idea
Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.
This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.
Learn more >>